National May 5, 2020

U.S. firm Gilead files for remdesivir approval in Japan

Gilead Sciences Inc. is seeking Japanese regulatory approval for remdesivir, a drug that potentially can reduce the impact of the coronavirus in some patients, according to sources. The health ministry is expected to move quickly and approve remdesivir using a fast-track process that allows for ...

Gilead experimental COVID-19 drug remdesivir fails in human trial

World Apr 24, 2020

Gilead experimental COVID-19 drug remdesivir fails in human trial

The experimental coronavirus treatment remdesivir has failed in its first randomized clinical trial, inadvertently released results showed Thursday, dampening expectations for the closely watched drug. A draft summary went online briefly on the website of the World Health Organization and was first reported by the ...